Background
==========

South Africa is burdened with a severe HIV epidemic, in which 28% of the adult population is infected. This is compounded by the occurrence of an equally severe TB epidemic. HIV-TB co-infection in South Africa has been estimated to account for 18% of all cases wordwide. The impact of TB co-infection on the immunopathogenesis of HIV in this high prevalence region has not been adequately assessed.

Methods
=======

In this cross-sectional study we examined the impact of TB co-infection on phenotypic and functional characteristics of CD8 T lymphocytes. A total of 25 HIV-1 infected individuals, 15 TB/HIV-1 co-infected individuals and 12 uninfected controls were included in the study. Phenotypic and functional marker expression was determined by flow cytometry.

Results
=======

HIV infection alone was associated with increased baseline expression compared to uninfected controls of TNF-alpha, perforin, granzyme A, PD-1, Fas (CD95), and FasL (CD95L), but not CD137(4-1BB) or IFN-gamma. TB co-infection resulted in additional increases in baseline expression of TNF-alpha, perforin, PD-1, and FasL (CD95L), as well as increased IFN-gamma. HIV-1 antigen (gag)-specific stimulation in vitro indicated that in HIV infection expression of activation and cytotoxicity markers CD137, IFN-gamma, TNF-alpha, Fas, FasL and CD107a/b were increased. In TB co-infection a reduction in CD107a/b up-regulation (degranulation) was observed, indicating functional impairment.

Conclusion
==========

TB co-infection reduced antigen-specific CTL functional activity, but increased other cytolytic markers (Fas, FasL, TNF-alpha) which could be involved in non-antigen-specific bystander target cell death. The expression of the co-stimulatory molecule CD137 correlated with CTL interferon-gamma production and levels of degranulation, confirming its usefulness as a putative surrogate marker of functional responsiveness. These data indicate that in addition to impacting on CD4 T cell function, TB co-infection leads to dysfunctional CTL responses.
